A Multicenter, Placebo-controlled, Double-blind Study to Evaluate the Efficacy and Safety of Zonisamide in the Treatment of Partial Seizures.
Phase of Trial: Phase III
Latest Information Update: 19 May 2017
At a glance
- Drugs Zonisamide (Primary)
- Indications Partial epilepsies
- Focus Therapeutic Use
- Sponsors Eisai Inc
- 11 Aug 2009 Actual end date (Jun 2008) added as reported by ClinicalTrials.gov.
- 11 Aug 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 23 Oct 2006 New trial record.